Selected as the top first-round idea from over 60,000 participants Strain patent application completed, product launch planned for Q1 next year
Sanare presents “Yudangdang” at the regional audition of “Startups for All.” Sanare passed this audition and advanced to the regional finals. Photo courtesy of Sanare
Health and bio startup Sanare (CEO Ko Hyun-san) has advanced to Round 3 of the Ministry of SMEs and Startups’ entrepreneurial competition project “Startups for All” with its independently developed probiotic capsule “Yudangdang.”
Sanare announced on the 27th that it had been selected as the best idea in Round 1 of this project, which received 62,944 applications. It then passed the regional audition and advanced to the regional finals, where 200 participants from across the country compete. The final top 100 and the winner will be determined in subsequent auditions.
Lactose intolerance is a condition in which the body cannot properly digest lactose, a sugar component in milk, leading to symptoms such as abdominal pain, bloating, and diarrhea. Lactose is found not only in dairy products but also in bread, processed foods, and protein supplements.
According to the company, Yudangdang is a product taken as one capsule per day. Sanare stated that its in-house laboratory compared the lactose-degrading enzyme activity of more than 1,100 strains isolated from domestically sourced food ingredients, and selected the final raw material after internal testing.
Sanare has filed a patent application for the strain and begun raw material production. It plans to unveil the product for the first time in December and officially launch it in the first quarter of next year.
CEO Ko said, “We have secured a proprietary strain with high lactose-degrading enzyme activity,” adding, “We will proceed with commercialization preparations without a hitch.”
Sanare was founded jointly by CEO Ko, Chief Marketing Officer (CMO) Kim Da-young, and Chief Technology Officer (CTO) Jeong Jin-joo.
Choi Yong-seok
AI-translated with ChatGPT. Provided as is; original Korean text prevails.
ⓒ dongA.com. All rights reserved. Reproduction, redistribution, or use for AI training prohibited.